Sa1781 GEF-H1 is Required for Antiviral Host Defense

Joo Hye Song,Yun Zhao,Hao-Sen Chiang,Song Liu,Ninghai Wang,Cox Terhorst,Megha G. Basavappa,Kate L. Jeffrey,Hans-Christian Reinecker
DOI: https://doi.org/10.1016/s0016-5085(14)61051-9
IF: 29.4
2014-01-01
Gastroenterology
Abstract:Cytokine Signalling (SOCS) 1 and 3 determined by quantitative real-time PCR.Results IFNβ was detected in the lamina propria of both control and IBD tissue and ISGs (MXA and 250AS) were expressed by intestinal T cells sorted from tissue.In vitro, IFNβ neutralisation reduced the frequency of pSTAT1+ intestinal T cells (n=6, p=0.05) and, in healthy controls, decreased the proportion of IL10-producing intestinal T cells (n=8, p=0.01).There was a trend for more IFNγ-producers (p=0.059) and IFNγ concentrations in supernatants were significantly increased (n=10, p=0.016).In IBD, intestinal T cells were more responsive to IFNβ in vitro, as assessed by ISG induction, (n=10 for patients and controls, p<0.03) and constitutive pSTAT1 was increased in T-cells isolated from non-inflamed mucosa of IBD patients compared with controls (n=30 IBD, 16 control, p=0.03).Concordantly, SOCS1 expression was decreased in IBD samples compared to controls (n=8 IBD, 6 control), p= 0.047).In contrast to control tissue, neutralisation of IFNβ in non-inflamed IBD samples led to a generalised increase in cytokine production, with a significant increase in the frequency of T cells producing all cytokines examined (IL-10, IFNγ, IL-17 and TNFα, n= 10).Discussion T1IFN is present in the mucosa of the human intestine and in health may have a regulatory role by selectively supporting T cell production of IL-10.There is increased responsiveness of the T1IFN pathway in T cells from non-inflamed tissue from IBD patients (increased pSTAT1 and ISGs, decreased SOCS1), associated with a generalised suppression of cytokine production.Thus, immunoregulatory effects of intestinal T1IFN are context dependent.This may help explain the varied clinical response to T1IFN as a therapeutic agent in IBD.
What problem does this paper attempt to address?